ELGX Related Analyst Ratings
-
With Q3 in Rearview Mirror, Endolgox's (ELGX) Pipeline in Focus
-
Oppenheimer Maintains an 'Outperform' on Endologix (ELGX); Q4 has Several Catalysts
-
BMO Capital Starts Endologix (ELGX) at Outperform
-
Piper Jaffray Upgrades Endologix (ELGX) to Overweight
-
Sidoti Starts Endologix (ELGX) at Buy
-
Lazard Capital Upgrades Endologix (ELGX) to Buy
-
Oppenheimer Positive on Endologix (ELGX) After Meeting with Management; Very Impressive Pipeline
-
Lazard Downgrades ISRG, AGN, ELGX, STJ, ZOLL to Neutral
-
Oppenheimer Lifts Numbers on Endologix (ELGX) On Higher Nellix Expectations
-
Shares of Endologix (ELGX) Turn Positive Following Lazard Upgrade
-
Lazard Capital Downgrades Endologix (ELGX) to Hold
-
Wedbush Raises Fair Value Estimate on Endologix (ELGX), Major Catalysts In Near-Future
-
Stephens Upgrades Endologix (ELGX) to Overweight
-
Baird Starts Endologix (ELGX) at Outperform
-
Oppenheimer Starts Endologix (ELGX) at Outperform
-
Wedbush Starts Endologix (ELGX) at Outperform; Promising Endovascular Pure Play
-
Capstone Investments Upgrades Endologix (ELGX) to Buy
-
CapStone Downgrades Endologix (ELGX) to Hold; Outlook May Be Marginal At Best
-
Piper Jaffray Initiates Coverage on Endologix (ELGX) with a Neutral; Waiting For Better Entry Point
-
Lazard Capital Starts Endologix (ELGX) at Buy
-
SunTrust Starts Endologix (ELGX) at Buy
-
Stanford Group Reit 'Buy' Rating on ELGX
Back to ELGX Stock Lookup
